Both erucin and sulforaphane were shown to be involved in the prevention and in the therapy of psoriasis and inflammatory skin diseases through the down-regulation of psoriasis-related cytokines, interleukin (IL)-12/23p40, IL-6 and tumor necrosis factor (TNF)-α [69,70]. The gene discussed is TNF; the disease is inflammatory skin disease.